Andarine Research Overview
Andarine (S-4) is a non-steroidal selective androgen receptor modulator belonging to the aryl-propionamide class of research compounds. Initially developed as a potential therapeutic intervention for osteoporosis and muscle wasting conditions, this compound demonstrates tissue-selective activity through partial agonism at androgen receptors. Research investigations conducted through Stroid UK Shop examine Andarine’s unique pharmacological profile, which shows preferential affinity for bone and muscle tissue over prostate in animal models. Preclinical studies indicate that S-4 exhibits oral bioavailability and demonstrates measurable anabolic effects in various research paradigms, making it a valuable tool for investigating selective androgen receptor signalling pathways.
Laboratory Research Applications
Scientific investigations examine Andarine’s role as a partial androgen receptor agonist in cellular and tissue-based research models. Studies evaluate its mechanism of action in bone metabolism research, where investigators analyse effects on osteoblast activity and mineral density parameters. Researchers studying Andarine compounds examine tissue selectivity profiles compared to traditional androgenic compounds, investigating reduced activity in reproductive tissues while maintaining anabolic effects in skeletal muscle research models. Laboratory protocols investigate S-4’s influence on gene expression patterns related to muscle protein synthesis and bone formation markers. Research applications extend to comparative studies with other SARM compounds to evaluate relative receptor binding affinities and tissue-specific responses. Investigators examine metabolic pathways affected by Andarine administration in controlled research environments, particularly focusing on protein synthesis regulation and calcium homeostasis mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 401900-40-1 |
| Molecular Formula | C₁₉H₁₈F₃N₃O₆ |
| Molecular Weight | 441.36 g/mol |
| Chemical Class | Non-steroidal SARM (aryl-propionamide) |
| Mechanism | Partial androgen receptor agonist |
| Storage Conditions | Room temperature, protect from light |
| Research Status | Development discontinued after Phase I |
Quality assurance protocols verify compound identity through analytical testing procedures. Storage recommendations maintain compound stability throughout research periods. Investigators should verify all specifications with analytical documentation provided. Research applications may explore comparative studies with peptide modulators to examine different approaches to tissue-selective receptor activation.
Research Compliance Statement
This Andarine compound is supplied exclusively for in-vitro laboratory research purposes and analytical investigations. Not approved for human consumption, therapeutic use, or any applications outside controlled research environments. Researchers must comply with applicable regulations governing research chemical handling and institutional review protocols. All investigations should follow established laboratory safety procedures and maintain proper documentation of research applications.
